Beijing, Beijing, China The company was established in Asia in China. The leading representative office of defined VC is situated in the Beijing.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the various public portfolio startups of the fund, we may underline Laviana Pharma Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2014.
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are Lotus Lake Ventures. In the next rounds fund is usually obtained by LYFE Capital, HY Capital, Crystal Pharmatech.
Funds with similar focus
| Fund Name | Location |
| Air Force Life Cycle Management Center | - |
| Ausum Ventures | California, San Francisco, United States |
| Cass Entrepreneurship Fund | England, London, United Kingdom |
| FLIR Systems | Oregon, United States, Wilsonville |
| Foundation Medicine | Cambridge, Massachusetts, United States |
| Greater Victoria Angel Network | British Columbia, Canada, Victoria |
| Innovation Birmingham Campus | Birmingham, England, United Kingdom |
| Intersil | California, Milpitas, United States |
| Jacopo Canclini | - |
| MetaCartel Ventures | - |
| Mingxin China Growth Fund | Beijing, Beijing, China |
| Motianshi Touzi | China, Guangdong, Guangzhou |
| Mubadala Investment Company | California, San Francisco, United States |
| Netac Technology | China, Guangdong, Shenzhen |
| New Generation Media | China, Haikou, Hainan |
| NISK Capital | Kenya, Nairobi, Nairobi Area |
| Startup Buddy | Gurgaon, Haryana, India |
| Validus Growth Investors | California, San Diego, United States |
| Yizheng Tiandao | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PhaBuilder | $55M | 02 Feb 2023 | - | ||
Zhongnong Meishu | $1M | 21 Feb 2022 | - | ||
Laviana Pharma | $4M | 01 Mar 2014 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PhaBuilder | $55M | 02 Feb 2023 | - | ||
Zhongnong Meishu | $1M | 21 Feb 2022 | - | ||
Laviana Pharma | $4M | 01 Mar 2014 | Dongcheng District, Beijing, China |
